drugset / Trial / NCT00002278
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
Completed
Janssen, LP
Treatment
Summary
To evaluate the safety and efficacy of diclazuril capsules as a treatment for cryptosporidial related diarrhea in AIDS patients who have been treated in the double-blind study # JRD 64,433/1101 and have relapsed, or de-novo patients who have been diagnosed with cryptosporidial related diarrhea and who meet the inclusion and exclusion criteria of this protocol.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclazuril | Small molecule | — | — |